Free cookie consent management tool by TermsFeed GPCRmd
× Due to a recent server update, this page will be slow for the next 1-2 hours. We apologize for any inconvenience this may cause.

Simulation report

Technical information

General information

Name: Beta-2 adrenergic receptor in complex with 6-bromo-n~2~-phenylquinazoline-2,4-diamine

PDB id: 6OBA

Activation state: Inactive

Description: Classical unbiased (NVT ensemble) complex flexibility assay.

Submitted by: GPCRmd community

System setup

Solvent type: TIP3P

Membrane type: Homogeneous

Membrane composition: POPC (99.1%), CLR (0.9%)

Ionic composition: Sodium ion (160 mM), Chloride (194 mM)

Number of molecules:

Water: 19480

POPC: 229

Chloride: 68

Sodium ion: 56

Cholesterol: 2

(-)-alprenolol: 1

6-bromo-n~2~-phenylquinazoline-2,4-diamine: 1

Beta-2 adrenergic receptor: 1

Total number of atoms: 94583

Simulation details

Software and version: ACEMD3, GPUGRID

Forcefield and version: CHARMM, c36 Jul 2020

Time step : 4.0 fs

Delta : 0.2 ns

Replicates: 3

Accumulated simulation time: 1.5 µs

Additonal parameters: Available at "Simulation protocol & starting files"

Simulation components

Ligands

Orthosteric ligand(s)

(-)-alprenolol

(1 molecule)


6-bromo-n~2~-phenylquinazoline-2,4-diamine

(1 molecule)


Receptor

Visualization and trajectory sharing powered by NGL viewer and MDSrv

Open with GPCRmd Workbench

Mutations

No mutations found



Other molecules



Water

Specific State ID: 5151

(19480 molecules)

H2O


POPC

Specific State ID: 5152

(229 molecules)


Sodium ion

Specific State ID: 5153

(56 molecules)

Na+


Chloride

Specific State ID: 5154

(68 molecules)

Cl-


Cholesterol

Specific State ID: 5166

(2 molecules)


(-)-alprenolol (orthosteric lig.)

Specific State ID: 5191

(1 molecule)


6-bromo-n~2~-phenylquinazoline-2,4-diamine (orthosteric lig.)

Specific State ID: 5212

(1 molecule)


PARTNER SERVERS

GPCRdb

GPCR-ModSim

GPCRM

NMRlipids

HomolWat

Hybrid MM/CG Webserver

CONTACT & LINKS

Documentation

Cite us

Privacy policy

Cookies policy

Disclaimer

Terms & Conditions

SUPPORTED BY

ERNEST (COST Action CA18133)

GLISTEN (COST Action CM1207)